Tempus AI (NASDAQ:TEM) Shares Down 3.1% – What’s Next?

Tempus AI, Inc. (NASDAQ:TEM)’s share price traded down 3.1% during trading on Monday . The stock traded as low as $44.28 and last traded at $46.33. 3,093,174 shares were traded during trading, a decline of 41% from the average session volume of 5,233,347 shares. The stock had previously closed at $47.83.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on TEM. JPMorgan Chase & Co. lowered shares of Tempus AI from an “overweight” rating to a “neutral” rating and lifted their price objective for the company from $50.00 to $55.00 in a research report on Tuesday, February 25th. Morgan Stanley raised their target price on shares of Tempus AI from $50.00 to $60.00 and gave the stock an “overweight” rating in a research note on Thursday, March 6th. TD Cowen reiterated a “buy” rating and set a $74.00 price target (up from $58.00) on shares of Tempus AI in a research note on Wednesday, February 5th. Wolfe Research downgraded shares of Tempus AI from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, February 26th. Finally, Needham & Company LLC lifted their price objective on Tempus AI from $56.00 to $70.00 and gave the company a “buy” rating in a report on Tuesday, February 25th. Six research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $61.18.

Tempus AI Price Performance

The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55. The business has a 50-day moving average price of $58.38 and a two-hundred day moving average price of $51.56.

Insiders Place Their Bets

In other Tempus AI news, major shareholder Bradley A. Keywell sold 265,000 shares of the firm’s stock in a transaction on Friday, January 17th. The stock was sold at an average price of $35.10, for a total transaction of $9,301,500.00. Following the completion of the transaction, the insider now owns 15,218,365 shares of the company’s stock, valued at approximately $534,164,611.50. This trade represents a 1.71 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CFO James William Rogers sold 23,030 shares of the company’s stock in a transaction on Tuesday, March 18th. The shares were sold at an average price of $45.97, for a total value of $1,058,689.10. Following the completion of the sale, the chief financial officer now owns 164,750 shares in the company, valued at $7,573,557.50. This represents a 12.26 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 5,598,969 shares of company stock worth $317,194,162.

Hedge Funds Weigh In On Tempus AI

Several institutional investors have recently added to or reduced their stakes in TEM. Wells Fargo & Company MN lifted its stake in shares of Tempus AI by 13.2% in the 4th quarter. Wells Fargo & Company MN now owns 2,384 shares of the company’s stock valued at $80,000 after purchasing an additional 278 shares in the last quarter. Geode Capital Management LLC raised its stake in shares of Tempus AI by 0.4% in the 3rd quarter. Geode Capital Management LLC now owns 133,171 shares of the company’s stock valued at $7,537,000 after acquiring an additional 539 shares during the period. Operose Advisors LLC purchased a new position in shares of Tempus AI in the 4th quarter valued at $25,000. Prestige Wealth Management Group LLC lifted its holdings in shares of Tempus AI by 910.4% during the 4th quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company’s stock valued at $36,000 after acquiring an additional 965 shares in the last quarter. Finally, Farther Finance Advisors LLC purchased a new stake in Tempus AI during the 4th quarter worth $34,000. 24.22% of the stock is currently owned by institutional investors and hedge funds.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.